Press Room

News / Jun 28, 2022

PhD student represents Hovione in the iconic photo featuring Curie and Einstein

CEFIC remakes the iconic 1927 photo. 34 renowned chemistry professors and 21 young European scientists recreate the iconic photo featuring Curie and Einstein

PhD student represents Hovione in the iconic photo feat. Curie and Einstein | Hovione

CEFIC (European Chemical Industry Council) celebrated its 50th anniversary with the recreation of an iconic photograph dating from 1927.

More than 30 Europe’s top chemistry professors, including two Nobel Prize laureates & 21 PhD students from all across the Europe gathered at the historic setting of the Brussels Metropole Hotel to recreate the iconic 1927Solvay picture featuring Marie Skłodowska-Curie and Albert Einstein.

Rute Mota, PhD student at Hovione under the EngIQ Program, was chosen to represent Portugal. EngIQ is a successful program that promotes the integration of students in a business environment, co-founded by APQuímica of which Hovione is associated.

The original photo included the best European scientists in the field of chemistry at the time and to show continuity a photo was taken this year bringing together some of the most promising PhD students in the field of chemistry at the European level (one per EU Member State).

 

CEFIC remakes iconic photo - PhD students | Hovione

 

Learn more about this initiative at CEFIC.org

 

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025